"GLP-3" is an informal term used in community discussions to refer to third-generation GLP-class peptides specifically retatrutide and other triple agonists
Higher maintenance doses were generally linked with greater weight loss, especially when patients stayed on treatment for longer
But they arent, and every doctor and nurse practitioner who follows me on social media knows that it is hard to pay the bills by accepting insurance for menopause care (this is also the same in Canada, given the dismal reimbursement from the provincial health plans)
Bodyweight decreased dose dependently with retatrutide at doses of 4 mg, 8 mg, and 12 mg. Lancet, Endicronology This has led researchers to investigate individualized dosing strategies rather than a one-size-fits-all protocol
Wilkinson, Francesco Zaccardi, Thomas Yates, Melanie J
The physiology of glucagon-like peptide 1